HMGB1 and tongue neoplasm: IHC staining of the ICD markers of HMGB1 and CRT in tongue tumors showed that PTT combined aPDL1 treatment led to the significantly decreased expression of HMGB1 and increased CRT exposure compared with the other groups (Fig. 6e, f).